Hip fracture is considered as the most severe osteoporotic fracture characterized by high disability and mortality in the elderly. Improved surgical techniques and multidisciplinary team play an active role in alleviating prognosis, which places higher demands on perioperative nursing. Dysfunction, complications, and secondary impact of anaesthesia and surgery add more difficulties to clinical nursing. Besides, there still lack clinical practices in perioperative nursing for elderly patients with hip fracture in China. In this context, led by the Orthopedic Nursing Committee of Chinese Nursing Association, the Expert consensus on clinical practice in perioperative nursing for elderly patients with hip fracture ( version 2023) is developed based on the evidence-based medicine. This consensus provides 11 recommendations on elderly patients with hip fracture from aspects of perioperative health education, condition monitoring and inspection, complication risk assessment and prevention, and rehabilitation, in order to provide guiding advices for clinical practice, improve the quality of nursing and ameliorate the prognosis of elderly patients with hip fracture.

恩替卡韦（entecavir，ETV）是当前慢性乙型肝炎（chronic hepatitis B，CHB）患者抗病毒治疗的一线药物之一。2005年美国食品与药品管理局与中国国家食品药品监督管理局相继批准ETV用于CHB治疗。为了规范与优化ETV的临床应用，《中华实验和临床感染病杂志（电子版）》编辑部、《中国肝脏病杂志（电子版）》编辑部曾于2009年邀请国内部分感染病学与肝病学领域专家召开了ETV临床应用专家研讨会，讨论形成了《2009年恩替卡韦临床应用专家共识》；并于2014年对该共识进行更新。近1年来，ETV治疗CHB患者的大样本长期随访数据不断公布，ETV治疗特殊人群患者的资料进一步积累。为将最新的ETV循证医学证据提供给广大肝病及感染病医务工作者，更好地指导ETV临床应用，《中华实验和临床感染病杂志（电子版）》、《中国肝脏病杂志（电子版）》与《Infection International（electronic version）》杂志编辑部再次组织相关专家，对ETV相关数据进行总结分析，形成了《恩替卡韦临床应用专家共识：2015年更新》。